1. Home
  2. SCPH vs LPTH Comparison

SCPH vs LPTH Comparison

Compare SCPH & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • LPTH
  • Stock Information
  • Founded
  • SCPH 2013
  • LPTH 1985
  • Country
  • SCPH United States
  • LPTH United States
  • Employees
  • SCPH N/A
  • LPTH N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • LPTH Semiconductors
  • Sector
  • SCPH Health Care
  • LPTH Technology
  • Exchange
  • SCPH Nasdaq
  • LPTH Nasdaq
  • Market Cap
  • SCPH 179.6M
  • LPTH 150.3M
  • IPO Year
  • SCPH 2017
  • LPTH 1996
  • Fundamental
  • Price
  • SCPH $3.24
  • LPTH $3.42
  • Analyst Decision
  • SCPH Strong Buy
  • LPTH Strong Buy
  • Analyst Count
  • SCPH 2
  • LPTH 3
  • Target Price
  • SCPH $15.00
  • LPTH $4.67
  • AVG Volume (30 Days)
  • SCPH 412.0K
  • LPTH 579.0K
  • Earning Date
  • SCPH 03-12-2025
  • LPTH 02-06-2025
  • Dividend Yield
  • SCPH N/A
  • LPTH N/A
  • EPS Growth
  • SCPH N/A
  • LPTH N/A
  • EPS
  • SCPH N/A
  • LPTH N/A
  • Revenue
  • SCPH $30,278,000.00
  • LPTH $32,049,325.00
  • Revenue This Year
  • SCPH $172.64
  • LPTH $12.63
  • Revenue Next Year
  • SCPH $131.43
  • LPTH $16.05
  • P/E Ratio
  • SCPH N/A
  • LPTH N/A
  • Revenue Growth
  • SCPH 303.87
  • LPTH N/A
  • 52 Week Low
  • SCPH $3.08
  • LPTH $1.04
  • 52 Week High
  • SCPH $6.54
  • LPTH $4.42
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 40.08
  • LPTH 59.16
  • Support Level
  • SCPH $3.27
  • LPTH $2.93
  • Resistance Level
  • SCPH $3.59
  • LPTH $3.22
  • Average True Range (ATR)
  • SCPH 0.20
  • LPTH 0.36
  • MACD
  • SCPH -0.01
  • LPTH -0.09
  • Stochastic Oscillator
  • SCPH 15.00
  • LPTH 41.86

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.

Share on Social Networks: